In whole‐exome sequencing (WES), target capture methods are used to enrich the sequences for uniform coverage across 37/62 Mb of exonic sequence, including 5' UTR, 3' UTR, Exonic regions of genes from fragmented total gDNA, followed by massively parallel, next generation sequencing of the captured fragments. The human exome encompasses approximately 1% of sequence of the complete genome and exome sequencing costs are approximately 10% of whole genome sequencing costs. Exome sequencing has been extensively used to deliver novel mutation in many diseases including cancer, diabetes Thalassemia, cystic fibrosis, cardiovascular disorders and Alzheimer disease. Xcelris Genomics provides you with the best solutions for human exome sequencing on Illumina NextSeq500 platform using paired end library. Barcoding/Indexing" will be carried to allow pooling of multiple samples in single lane. This allows to identify variations in individual DNA sequence and mapped back to the individual medical concerns in an effort to discover the cause of the medical disorder.